COOKSON PEIRCE & CO INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
COOKSON PEIRCE & CO INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$65
-99.9%
50,000
+316.7%
0.00%0.0%
Q3 2022$59,000
-96.2%
12,000
-87.9%
0.00%
-96.2%
Q4 2020$1,545,000
+194.3%
99,030
+258.2%
0.10%
+118.8%
Q1 2018$525,000
+27.4%
27,650
+10.0%
0.05%
+23.1%
Q4 2017$412,000
-40.5%
25,140
-45.6%
0.04%
-45.8%
Q3 2017$693,000
+118.6%
46,200
+28.4%
0.07%
+100.0%
Q2 2017$317,00035,9900.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders